Mallinckrodt
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Mallinckrodt sits in the top decile of US sponsors by registered trial count (#307 of 15,742 sponsors by registered trial count).
Mallinckrodt: 69 sponsored US clinical trials, none currently recruiting.
Mallinckrodt sponsors 69 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 52 completed. 34 of these trials are in Phase 3-4 (later-stage) and 31 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Keratitis, with 1 trials.
Top-decile sponsor footprint
Mallinckrodt ranks in the top decile of sponsors by registered trial count (#307 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
52 of 69 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
69 total, page 1 of 2
Impact of Acthar on Everyday Life of Participants With Severe Keratitis
NCT04169061
MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
NCT03712280
Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
NCT03656692
Acthar Gel in Participants With Pulmonary Sarcoidosis
NCT03320070
Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension
NCT03132428
Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)
NCT03068754
Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain Patients
NCT02321319
Acthar Gel for Active Systemic Lupus Erythematosus (SLE)
NCT02953821
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis
NCT02919761
Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects
NCT02966860
Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1
NCT02770716
Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain
NCT02746263
Drug Interactions Between Morphine and Orally or IV Administered Acetaminophen
NCT02848729
Reduction in Pain Intensity Following IV or Oral Pain-relieving Products
NCT02678416
Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse
NCT02633033
Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
NCT02508935
Topical Raplixa for Surgical Bleeding in Children
NCT02117349
Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation
NCT01993875
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
NCT01906658
Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors
NCT02040558
Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease
NCT01753401
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
NCT01722864
Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain
NCT01743625
A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients
NCT01635101
A Study of Fibrocaps™ in Surgical Bleeding
NCT01527357
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
NCT01601236
Assessing Relapse in Multiple Sclerosis (ARMS) Questionnaire
NCT01547351
Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)
NCT01380535
Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension
NCT01484652
Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain
NCT01451385
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
NCT01386554
U.S. Study of Fibrocaps in Surgical Hemostasis
NCT01256164
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
NCT01143246
Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel
NCT01202799
Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis
NCT01119898
Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
NCT00931632
Pharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal Function
NCT00879645
Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients
NCT00598559
Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients
NCT00598702
Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop Pain
NCT00564486
Study of the Efficacy and Safety of Intravenous vs Oral Acetaminophen for Treatment of Fever in Healthy Adult Males
NCT00564629
Safety and Pharmacokinetic (PK) Study of Intravenous (IV) Acetaminophen Administration in Pediatric Inpatients
NCT00493246
Safety of Intravenous Acetaminophen Vs Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males
NCT00493311
Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery
NCT00399568
Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc.
NCT01173627
Nitric Oxide in Myocardial Infarction Size
NCT00568061
The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients
NCT00782652
Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease
NCT00282503
Fed Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets
NCT00853268
Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets
NCT00853892
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 15 |
| Phase 3 | 22 |
| Phase 4 | 12 |
How the Mallinckrodt archive is shaped
69 indexed studies, none listed as recruiting (0% open); 52 completed (75%).
Phase mix: 34 late (III/IV) vs 31 early (I/II) (balanced across stages).
Top condition: Keratitis (1 trial), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Mallinckrodt: archived-pipeline peers nationwide
Peers matched on 69 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Mallinckrodt sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 69 archived trials
- Providence Health & Services · 69 trials · 7% recruiting
- Texas Tech University · 69 trials · 17% recruiting
- University of Colorado, Boulder · 69 trials · 22% recruiting
- Procter and Gamble · 70 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Mallinckrodt page
69 registered trials is a research-attention snapshot, not an endorsement of Mallinckrodt or any single study.
- None of Mallinckrodt's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Keratitis is the condition Mallinckrodt studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Keratitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Mallinckrodt pipeline card: 69 registered trials from official public datasets.Report a data error.